Hansa Biopharma has partnered with Cradle to use its AI-driven protein design platform to develop new immunomodulatory therapies for autoimmune diseases. This collaboration aims to speed up the discovery and optimization of novel therapeutic candidates, leveraging Cradle's end-to-end platform that supports multi-parameter optimization and active learning. Hansa's lead product, imlifidase, is already commercialized in Europe and under FDA review in the U.S. The partnership reflects Hansa's strategic investment in AI to enhance drug discovery and reduce development timelines, potentially saving significant R&D costs.
Hansa Biopharma's AI-driven protein design partnership is noted alongside Pluang's Health-sector market snapshot. For readers following health stocks, here is Pluang's market snapshot as of Oct 01, 2026 17:01 WIB: of 100 priced US health-sector stocks, 34 rose and 56 fell. Notable movers include FLNA (Cassava Sciences Inc) at USD 0.97 with a 1-day change of +9.48% and Pluang order activity 99% Sell / 1% Buy, CTXR (Citius Pharmaceuticals Inc) at USD 0.56 with +5.08% and 66% Sell / 34% Buy, and CGC (Canopy Growth Corp) at USD 0.93 with +3.77% and 8% Sell / 92% Buy.
Cal-Maine Foods reported a $58.6 million net loss and a 42% drop in net sales, driven by lower conventional egg prices. An analyst downgraded the stock to Hold with a $70 price target, reflecting a modest 2.85% upside from current levels. Despite cha...
PNC Financial Services Group received mixed analyst ratings on October 1, 2026. Evercore ISI maintained an Outperform rating but lowered its price target to $265 from $285, citing strong net interest income growth but caution on expenses and asset qu...
Accenture reported fiscal Q4 2026 earnings that exceeded analyst expectations with EPS of $3.29, up 46% year-over-year, and revenue of $18.68 billion, a 6% increase. The company also saw a 4% rise in new bookings to $22.17 billion, reflecting strong ...
Analysts have downgraded PepsiCo and lowered its price targets due to weak stock performance and sales challenges in its Frito-Lay North America segment. Despite efforts to improve products, sales remain sluggish, raising concerns about PepsiCo's ope...
Ormat Technologies is advancing its geothermal energy projects with $35 million in funding from the U.S. Department of Energy to develop power plants in Nevada and Utah. Despite this progress and partnerships like the one with Sage Geosystems to buil...
